Amgen Extends Oncology Portfolio with $1.9 Billion Five Prime Acquisition
Amgen and Five Prime Therapeutics, a clinical-stage biotech corporation focusing on discovering immuno-oncology and personalized cancer treatments, announced on the
Read moreAmgen and Five Prime Therapeutics, a clinical-stage biotech corporation focusing on discovering immuno-oncology and personalized cancer treatments, announced on the
Read moreMerck & Co. is set to boosts its autoimmune diseases pipeline through the acquisition of Pandion Therapeutics for circa $1.85
Read moreThe U.S. Food and Drug Administration has revisited data on the stability of the Pfizer/BioNTech COVID-19 doses at normal pharmaceutical
Read moreThe U.S. FDA has approved the first single-shot COVID-19 jab, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson,
Read moreThe cutting-edge multispectral tissue cytometry hardware TissueFAXS SPECTRA, developed by TissueGnostics, has the unique ability to enable multispectral imaging of
Read moreThe modern brightfield and fluorescence scanning system by TissueGnostics offers unparalleled flexibility for researchers working on tissue-based cell culture analysis
Read moreTissueGnostics has launched a new cutting-edge compact digital brightfield slide scanner with remote real-time viewing and live stitching modes combined
Read moreRoche has revealed that their assay Elecsys® GDF-15 assay has been approved as a companion diagnostic (CDx) in cancer therapy
Read moreThe next-gen TissueFAXS Q confocal imaging systems are highly flexible scanning platforms which offer the advantages of both laser-free ultra-fast
Read moreThe StrataQuest AI-assisted high-content screening (HCS) image cytometry software offers solutions for multiple applications in analysing large volumes of complex
Read more